Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Enzon Pharmaceuticals Inc

+ Add to Watchlist

ENZN:US

1.4215 USD 0.0785 5.23%

As of 12:02:39 ET on 04/28/2015.

Company Profile for Enzon Pharmaceuticals Inc (ENZN)

Enzon Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes therapeutics to treat life-threatening diseases. The Company has developed several products, including PEG-INTRON. Enzon's product-focused strategy includes a drug development program that leverages its PEG modification and single-chain antibody (SCA) technologies.

Contact Information

Enzon Pharmaceuticals Inc

20 Kingsbridge Road
Piscataway, NJ 08854
United States
Phone: 1-732-980-4500

Key Executives for Enzon Pharmaceuticals Inc (ENZN)

Richard L FeinsteinVP:Finance/Principal Financial Ofcr

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil